Tiziana Life Sciences to expedite development of TZLS-501 for COVID-19
TZLS-501 is a novel fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.